Business Context and Reporting Period
Cytosorbents Corporation filed a Form 8-K Current Report on June 26, 2018. The filing reports a corporate event regarding the company's inclusion in major market indices.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is limited to reporting a specific corporate event.
Material Changes
On June 26, 2018, Cytosorbents Corporation announced it has been added to the Russell 3000 Index and its subcomponent, the Russell 2000 Index. This is a change in market index composition rather than a change in operational or financial performance.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, risk factors, contingencies, or discussion of unusual items. The full text of the press release regarding the index inclusion is filed as Exhibit 99.1.
Investor Verification Checklist
- Verify the effective date of the Russell 3000 and Russell 2000 index inclusion.
- Review the impact of index inclusion on the company's stock liquidity and trading volume.
- Check for any subsequent filings regarding changes in index composition.